Details of the Drug Reposition

General Information of This Drug (ID: DML4BZ2)

• Drug Name: SKL20540 (DML4BZ2)

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Immune dysregulation	DISZV2UF	4A01.2	Phase 1	[1]
Complete androgen insensitivity syndrome	DISQL418	LD2A.4	Phase 1	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)